Home Cart 0 Sign in  

[ CAS No. 20776-48-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 20776-48-1
Chemical Structure| 20776-48-1
Structure of 20776-48-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 20776-48-1 ]

Related Doc. of [ 20776-48-1 ]

Alternatived Products of [ 20776-48-1 ]

Product Details of [ 20776-48-1 ]

CAS No. :20776-48-1 MDL No. :MFCD03618455
Formula : C7H6BrNO2 Boiling Point : -
Linear Structure Formula :- InChI Key :BNQPROAXWQCNKO-UHFFFAOYSA-N
M.W : 216.03 Pubchem ID :10560649
Synonyms :

Calculated chemistry of [ 20776-48-1 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 2.0
Molar Refractivity : 45.51
TPSA : 63.32 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.66 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.06
Log Po/w (XLOGP3) : 2.76
Log Po/w (WLOGP) : 1.74
Log Po/w (MLOGP) : 0.64
Log Po/w (SILICOS-IT) : 1.18
Consensus Log Po/w : 1.48

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -3.26
Solubility : 0.12 mg/ml ; 0.000555 mol/l
Class : Soluble
Log S (Ali) : -3.74
Solubility : 0.0389 mg/ml ; 0.00018 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.27
Solubility : 1.16 mg/ml ; 0.00536 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.29

Safety of [ 20776-48-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 20776-48-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 20776-48-1 ]
  • Downstream synthetic route of [ 20776-48-1 ]

[ 20776-48-1 ] Synthesis Path-Upstream   1~13

  • 1
  • [ 20776-48-1 ]
  • [ 77287-34-4 ]
  • [ 147006-47-1 ]
Reference: [1] Journal of Organic Chemistry, 1952, vol. 17, p. 149,153
[2] Patent: WO2017/100591, 2017, A1, . Location in patent: Paragraph 00217
  • 2
  • [ 75-44-5 ]
  • [ 20776-48-1 ]
  • [ 77603-45-3 ]
Reference: [1] Australian Journal of Chemistry, 1999, vol. 52, # 11, p. 1061 - 1069
[2] Journal of Labelled Compounds and Radiopharmaceuticals, 1996, vol. 38, # 9, p. 835 - 845
  • 3
  • [ 32315-10-9 ]
  • [ 20776-48-1 ]
  • [ 77603-45-3 ]
Reference: [1] Journal of Agricultural and Food Chemistry, 2015, vol. 63, # 31, p. 6883 - 6889
  • 4
  • [ 20780-72-7 ]
  • [ 20776-48-1 ]
YieldReaction ConditionsOperation in experiment
67% With dihydrogen peroxide; sodium hydroxide In water at 55℃; for 0.5 h; Commercially available 4-bromoisatin (2.50 g, 11.1 mmol) was dissolved in a 1.5 mol/L sodium hydroxide aqueous solution (20 mL), and 33percent hydrogen peroxide water (1 mL) was dropped at 55°C. After being stirred at 55°C for 30 minutes, the reaction mixture was cooled to room temperature, neutralized with 2.0 mol/L hydrochloric acid, and purified with HP-20 resin to give 2-amino-6-bromobenzoic acid (1.60 g, 67percent).
Reference: [1] Patent: EP2708540, 2014, A1, . Location in patent: Paragraph 0092
[2] Proceedings of the Royal Society of London, Series B: Biological Sciences, 1958, vol. 148, p. 481,488
[3] Patent: WO2011/28741, 2011, A1, . Location in patent: Page/Page column 202
[4] ACS Medicinal Chemistry Letters, 2016, vol. 7, # 9, p. 831 - 834
  • 5
  • [ 38876-67-4 ]
  • [ 20776-48-1 ]
Reference: [1] Patent: US2005/182045, 2005, A1, . Location in patent: Page/Page column 56
  • 6
  • [ 38792-45-9 ]
  • [ 20776-48-1 ]
Reference: [1] Journal of Labelled Compounds and Radiopharmaceuticals, 1996, vol. 38, # 9, p. 835 - 845
[2] Justus Liebigs Annalen der Chemie, 1912, vol. 388, p. 34
[3] Australian Journal of Chemistry, 1999, vol. 52, # 11, p. 1061 - 1069
  • 7
  • [ 67866-91-5 ]
  • [ 20776-48-1 ]
Reference: [1] Australian Journal of Chemistry, 1999, vol. 52, # 11, p. 1061 - 1069
[2] Journal of Labelled Compounds and Radiopharmaceuticals, 1996, vol. 38, # 9, p. 835 - 845
[3] Justus Liebigs Annalen der Chemie, 1912, vol. 388, p. 34
  • 8
  • [ 55289-36-6 ]
  • [ 20776-48-1 ]
Reference: [1] Australian Journal of Chemistry, 1999, vol. 52, # 11, p. 1061 - 1069
[2] Journal of Labelled Compounds and Radiopharmaceuticals, 1996, vol. 38, # 9, p. 835 - 845
  • 9
  • [ 55289-35-5 ]
  • [ 20776-48-1 ]
Reference: [1] Australian Journal of Chemistry, 1999, vol. 52, # 11, p. 1061 - 1069
  • 10
  • [ 118-92-3 ]
  • [ 20776-48-1 ]
Reference: [1] Chemistry - A European Journal, 2014, vol. 20, # 50, p. 16759 - 16763
  • 11
  • [ 20776-48-1 ]
  • [ 1293915-42-0 ]
Reference: [1] Patent: WO2012/52753, 2012, A1,
[2] Patent: WO2013/136075, 2013, A1,
  • 12
  • [ 20776-48-1 ]
  • [ 57-13-6 ]
  • [ 114703-12-7 ]
Reference: [1] Antimicrobial Agents and Chemotherapy, 2017, vol. 61, # 6,
  • 13
  • [ 20776-48-1 ]
  • [ 959237-68-4 ]
Reference: [1] Antimicrobial Agents and Chemotherapy, 2017, vol. 61, # 6,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 20776-48-1 ]

Aryls

Chemical Structure| 474330-54-6

[ 474330-54-6 ]

Methyl 5-amino-2-bromo-4-methylbenzoate

Similarity: 0.90

Chemical Structure| 6942-37-6

[ 6942-37-6 ]

Methyl 5-amino-2-bromobenzoate

Similarity: 0.90

Chemical Structure| 98545-64-3

[ 98545-64-3 ]

Methyl 4-amino-2-bromobenzoate

Similarity: 0.90

Chemical Structure| 42237-85-4

[ 42237-85-4 ]

3-Amino-5-bromobenzoic acid

Similarity: 0.88

Chemical Structure| 124341-06-6

[ 124341-06-6 ]

6-Amino-3-bromo-2-methylbenzoic acid

Similarity: 0.86

Bromides

Chemical Structure| 474330-54-6

[ 474330-54-6 ]

Methyl 5-amino-2-bromo-4-methylbenzoate

Similarity: 0.90

Chemical Structure| 6942-37-6

[ 6942-37-6 ]

Methyl 5-amino-2-bromobenzoate

Similarity: 0.90

Chemical Structure| 98545-64-3

[ 98545-64-3 ]

Methyl 4-amino-2-bromobenzoate

Similarity: 0.90

Chemical Structure| 42237-85-4

[ 42237-85-4 ]

3-Amino-5-bromobenzoic acid

Similarity: 0.88

Chemical Structure| 124341-06-6

[ 124341-06-6 ]

6-Amino-3-bromo-2-methylbenzoic acid

Similarity: 0.86

Amines

Chemical Structure| 474330-54-6

[ 474330-54-6 ]

Methyl 5-amino-2-bromo-4-methylbenzoate

Similarity: 0.90

Chemical Structure| 6942-37-6

[ 6942-37-6 ]

Methyl 5-amino-2-bromobenzoate

Similarity: 0.90

Chemical Structure| 98545-64-3

[ 98545-64-3 ]

Methyl 4-amino-2-bromobenzoate

Similarity: 0.90

Chemical Structure| 42237-85-4

[ 42237-85-4 ]

3-Amino-5-bromobenzoic acid

Similarity: 0.88

Chemical Structure| 124341-06-6

[ 124341-06-6 ]

6-Amino-3-bromo-2-methylbenzoic acid

Similarity: 0.86

Carboxylic Acids

Chemical Structure| 42237-85-4

[ 42237-85-4 ]

3-Amino-5-bromobenzoic acid

Similarity: 0.88

Chemical Structure| 124341-06-6

[ 124341-06-6 ]

6-Amino-3-bromo-2-methylbenzoic acid

Similarity: 0.86

Chemical Structure| 2840-02-0

[ 2840-02-0 ]

5-Amino-2-bromobenzoic acid

Similarity: 0.85

Chemical Structure| 206548-13-2

[ 206548-13-2 ]

2-Amino-5-bromo-3-methylbenzoic acid

Similarity: 0.84

Chemical Structure| 20776-50-5

[ 20776-50-5 ]

2-Amino-4-bromobenzoic acid

Similarity: 0.84